Sulindac
Sulindac is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve the pain and inflammation of several types of arthritis, acute painful shoulder and acute gout flares.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 12 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Sulindac (Clinoril) is an older standby NSAID, or nonsteroidal anti-inflammatory drug, on the market since about 1978 and available as a generic, that eases the pain and swelling of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis (arthritis of the spine), painful shoulder and gout flares by blocking prostaglandins, chemicals behind inflammation. Most people tolerate it reasonably well, though stomach pain, indigestion and nausea are common, which is why it is taken with food. Its boxed warning covers heart attack, stroke and serious stomach or intestinal bleeding, so use the lowest dose for the shortest time and get help fast for black stools, chest pain or one-sided weakness.
Clinical pearls
- Avoid aspirin with sulindac, because aspirin lowers levels of sulindac's active form and adds stomach risk.
- Do not add over-the-counter ibuprofen or naproxen for extra relief, since doubling up on NSAIDs raises stomach bleeding risk.
- Tell whoever manages your lithium, warfarin, methotrexate or water pill that you started sulindac, since each interaction needs watching.
- Call your doctor about ankle swelling, rapid weight gain or much less urine, which can signal fluid retention or kidney strain.
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾
Sulindac and other NSAIDs can raise the risk of heart attack, stroke and serious stomach or intestinal bleeding, which can be fatal.
Heart risk: Heart attack and stroke can happen early in treatment and may become more likely the longer you take it. Sulindac must not be used around the time of CABG heart surgery.
Stomach risk: NSAIDs can cause bleeding, ulcers and holes (perforation) in the stomach or intestines. This can happen at any time and without warning symptoms. Older adults are at higher risk.
Patient information guide A plain-language walkthrough of Sulindac, written from its FDA label.
What Sulindac is used for
▾
Sulindac is an NSAID used for the relief of signs and symptoms of these conditions:
- Osteoarthritis
- Rheumatoid arthritis
- Ankylosing spondylitis
- Acute painful shoulder (acute subacromial bursitis/supraspinatus tendinitis)
- Acute gouty arthritis
Sulindac tablets can be used for short or long periods. Their safety and effectiveness have not been established in rheumatoid arthritis patients who are Functional Class IV (largely or wholly bedridden or wheelchair-bound).
How Sulindac works
▾
Sulindac is an NSAID. It reduces inflammation, pain and fever in animal models. Like other NSAIDs, it may work by blocking prostaglandin synthesis, although the exact mechanism is not fully understood.
Your body converts sulindac into an active form called the sulfide metabolite. This form is responsible for most of the drug's activity.
Sulindac dosage
▾
Sulindac tablets are taken by mouth twice a day with food. Your prescriber will adjust the dose and frequency based on your response. Use the lowest effective dose for the shortest time that meets your goals.
- For arthritis conditions, some people respond within a week, while others take longer.
- For acute painful shoulder, treatment is usually 7 to 14 days.
- For acute gout, treatment is usually about 7 days.
Follow your prescriber's directions and the label. Ask your pharmacist what to do if you miss a dose.
Dosing details from the FDA-approved label
From the Sulindac prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis
- Recommended starting dosage is 150 mg twice a day, administered orally with food
- The dosage may be lowered or raised depending on the response
- Maximum: 400 mg per day; dosages above 400 mg per day are not recommended
- Prompt response (within one week) expected in about one-half of patients; others may require longer
- Acute painful shoulder (acute subacromial bursitis/supraspinatus tendinitis)
- 200 mg twice a day, administered orally with food
- After a satisfactory response the dosage may be reduced according to the response
- Therapy for 7-14 days is usually adequate
- Maximum: 400 mg per day; dosages above 400 mg per day are not recommended
- Take with food
- Acute gouty arthritis
- 200 mg twice a day, administered orally with food
- After a satisfactory response the dosage may be reduced according to the response
- Therapy for 7 days is usually adequate
- Maximum: 400 mg per day; dosages above 400 mg per day are not recommended
- Take with food
Read the label’s full dosing text
DOSAGE AND ADMINISTRATION Carefully consider the potential benefits and risks of sulindac tablets and other treatment options before deciding to use sulindac tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). After observing the response to initial therapy with sulindac tablets, the dose and frequency should be adjusted to suit an individual patient's needs. Sulindac tablets should be administered orally twice a day with food. The maximum dosage is 400 mg per day. Dosages above 400 mg per day are not recommended. In osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, the recommended starting dosage is 150 mg twice a day. The dosage may be lowered or raised depending on the response. A prompt response (within one week) can be expected in about one-half of patients with osteoarthritis, ankylosing spondylitis, and rheumatoid arthritis. Others may require longer to respond. In acute painful shoulder (acute subacromial bursitis/supraspinatus tendinitis) and acute gouty arthritis, the recommended dosage is 200 mg twice a day. After a satisfactory response has been achieved, the dosage may be reduced according to the response. In acute painful shoulder, therapy for 7–14 days is usually adequate. In acute gouty arthritis, therapy for 7 days is usually adequate. **Incidence between 3% and 9%. Those reactions occurring in 1% to 3% of patients are not marked with an asterisk.
Read the full Dosage and Administration section on DailyMed →
Sulindac side effects
▾
The most common side effects involve the stomach and digestion.
Common side effects
- Stomach or abdominal pain
- Indigestion
- Nausea, with or without vomiting
- Diarrhea or constipation
- Gas, cramps or loss of appetite
- Rash or itching
- Dizziness or headache
- Ringing in the ears (tinnitus) or swelling (edema)
- Dizziness, headache and nervousness
When to get medical help
- Call 911 or get emergency help for signs of a severe allergic reaction, such as trouble breathing, wheezing or facial swelling.
- Get help right away for signs of a heart attack or stroke. Examples are chest pain, shortness of breath, weakness on one side or slurred speech.
- Call your doctor if you have black or bloody stools, vomit blood, or have severe stomach pain. These can be signs of stomach or intestinal bleeding, ulcers or perforation.
- Stop the medicine and call your doctor at the first sign of a skin rash, blistering or peeling.
- Stop and call your doctor if you have fever, rash, swollen glands or facial swelling. These can be signs of a serious reaction called DRESS.
- Call your doctor if you have yellow skin or eyes (jaundice), dark urine or unexplained fever. These can be signs of liver problems.
- Call your doctor if you have swelling, rapid weight gain or worsening shortness of breath. These can be signs of fluid retention or worsening heart failure.
- Call your doctor if you notice much less urine than usual, which can be a sign of kidney problems.
Get medical help for black or bloody stools, vomiting blood, chest pain, trouble breathing, a serious skin rash, yellow skin or eyes, or swelling of the face.
Sulindac warnings and precautions
▾
- Heart attack and stroke: the risk can start early and may rise with longer use. Sulindac must not be used around CABG surgery.
- Stomach and intestinal bleeding, ulcers and perforation: these can occur without warning and can be fatal. Older adults, people with a past ulcer or bleeding, smokers, alcohol users, and people taking steroid pills or blood thinners are at higher risk.
- Blood pressure and heart failure: sulindac can raise blood pressure, cause fluid retention and worsen heart failure.
- Liver and kidney effects: liver test changes can occur, and rare severe liver reactions have been reported. Kidney injury is possible, especially in people with kidney disease, heart failure or liver problems, or those taking diuretics or ACE inhibitors.
- Skin and allergic reactions: serious skin reactions, DRESS and anaphylaxis can occur without warning. Stop the drug at the first sign of rash.
- Pregnancy: avoid at about 30 weeks and later. Use at about 20 weeks or later may harm the baby's kidneys.
Sulindac interactions
▾
Sulindac can clash with several common medicines.
- Aspirin: lowers sulindac's active form and increases stomach side effects.
- Other NSAIDs: more stomach risk with little added benefit.
- Warfarin and other blood thinners: a higher risk of serious bleeding together.
- ACE inhibitors, ARBs and diuretics: weaker blood pressure or fluid effects, and a possible kidney strain.
- Lithium: levels may rise.
- Methotrexate and cyclosporine: possible increased toxicity.
- DMSO: should not be used with sulindac.
- Diflunisal: lowers sulindac's active form.
Interactions listed in the FDA-approved label
From the Sulindac prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- ACE-inhibitors and angiotensin II antagonists: NSAIDs may diminish the antihypertensive effect of ACE-inhibitors and angiotensin II antagonists, and in patients with compromised renal function co-administration may further deteriorate renal function, including possible acute renal failure, which is usually reversible. Give consideration to these interactions and monitor renal function periodically in patients receiving ACEIs or AIIAs and NSAIDs in combination.
- Acetaminophen: Acetaminophen had no effect on the plasma levels of sulindac or its sulfide metabolite.
- Aspirin: Aspirin significantly depressed plasma levels of the active sulfide metabolite and the combination showed an increase in the incidence of gastrointestinal adverse experiences without a favorable effect on therapeutic response. The combination is not recommended.
- Cyclosporine: NSAIDs given with cyclosporine have been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin. Use NSAIDs with caution in patients taking cyclosporine and monitor renal function carefully.
- Diflunisal: Concomitant use in normal volunteers lowered plasma levels of the active sulindac sulfide metabolite by approximately one-third.
- Diuretics (furosemide and thiazides): Sulindac can reduce the natriuretic effect of furosemide and thiazides in some patients, attributed to inhibition of renal prostaglandin synthesis. Observe the patient closely for signs of renal failure and to assure diuretic efficacy.
- DMSO: Concomitant administration has been reported to reduce plasma levels of the active sulfide metabolite, potentially reduce efficacy, and cause peripheral neuropathy. DMSO should not be used with sulindac.
- Lithium: NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance; mean minimum lithium concentration increased 15% and renal clearance decreased by approximately 20%. Observe subjects carefully for signs of lithium toxicity.
- Methotrexate: NSAIDs have been reported to competitively inhibit methotrexate accumulation in rabbit kidney slices, which may indicate they could enhance methotrexate toxicity. Use caution when NSAIDs are given with methotrexate.
- Other NSAIDs: Concomitant use increases the possibility of gastrointestinal toxicity, with little or no increase in efficacy. Concomitant use is not recommended.
Read the label’s full interactions text
Drug Interactions ACE-Inhibitors and Angiotensin II Antagonists Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors and angiotensin II antagonists. These interactions should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors or angiotensin II antagonists. In some patients with compromised renal function (e.g., elderly patients or patients who are volume-depleted, including those on diuretic therapy) who are being treated with non-steroidal anti-inflammatory drugs, the co-administration of an NSAID and an ACE-inhibitor or an angiotensin II antagonist may result in further deterioration of renal function, including possible acute renal failure, which is usually reversible. Therefore, monitor renal function periodically in patients receiving ACEIs or AIIAs and NSAIDs in combination therapy. Acetaminophen Acetaminophen had no effect on the plasma levels of sulindac or its sulfide metabolite. Aspirin The concomitant administration of aspirin with sulindac significantly depressed the plasma levels of the active sulfide metabolite. A double-blind study compared the safety and efficacy of sulindac tablets 300 or 400 mg daily given alone or with aspirin 2.4 g/day for the treatment of osteoarthritis. The addition of aspirin did not alter the types of clinical or laboratory adverse experiences for sulindac tablets; however, the combination showed an increase in the incidence of gastrointestinal adverse experiences. Since the addition of aspirin did not have a favorable effect on the therapeutic response to sulindac tablets, the combination is not recommended. Cyclosporine Administration of non-steroidal anti-inflammatory drugs concomitantly with cyclosporine has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin. NSAIDs should be used with caution in patients taking cyclosporine, and renal function should be carefully monitored.
Excerpted — the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Sulindac
▾
- Do not use it if you are allergic to sulindac or have had asthma, hives or allergic reactions to aspirin or other NSAIDs.
- Do not use it around CABG heart surgery.
- Tell your doctor about heart disease, a recent heart attack, heart failure or high blood pressure.
- Tell your doctor about past ulcers or stomach bleeding.
- Tell your doctor about kidney or liver disease. It is not recommended in advanced kidney disease.
- Older adults face a higher risk of stomach and kidney problems.
- Tell your doctor if you are pregnant or plan to be. It is not known if sulindac passes into human milk.
Sulindac overdose
▾
Overdose cases have been reported, and rarely deaths have occurred. Signs can include stupor, coma, low urine output and low blood pressure. Get emergency medical help right away. Treatment may include emptying the stomach, close observation and supportive care.
What Sulindac does in the body
▾
Sulindac has anti-inflammatory, pain-relieving and fever-reducing activity in animal models. Its action may relate to blocking prostaglandin synthesis. Its activity comes mainly from the sulfide metabolite, which blocks cyclooxygenase. Sulindac may affect kidney function less than some other NSAIDs, but kidney problems have still been reported.
How your body processes Sulindac
▾
Your body converts sulindac to an active sulfide form and an inactive sulfone form. The active form accounts for most of the drug's effect. About 50% of a dose is excreted in the urine and about 25% in the feces. The effective half-life is about 7.8 hours for sulindac and 16.4 hours for the active form. With twice-daily dosing, levels build up in the body. Older adults clear the drug more slowly through the kidneys.
How to store Sulindac
▾
Store at 20° to 25°C (68° to 77°F). DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINER.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Supplements & herbs that interact with Sulindac
34 supplements and herbal products have documented interactions with Sulindac in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 5
- Moderate · 18
- Minor · 11
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Sulindac has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
Sulindac: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Sulindac — the kind of thing our pharmacy team would talk through with you at the counter.
What is sulindac for?
▾
How should I take it?
▾
What side effects should I expect?
▾
When should I call my doctor right away?
▾
Can I take aspirin or other pain relievers with it?
▾
Is sulindac safe during pregnancy?
▾
Is Sulindac available over the counter?
▾
When was Sulindac first available?
▾
Who makes Sulindac?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Sulindac on HelloPharmacist
Sulindac forms and strengths (how it comes)
Sulindac is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Sulindac inactive ingredients by manufacturer.
Tablet
How this form is used
- Sulindac tablets relieve signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
- Sulindac tablets are also used for acute painful shoulder and acute gouty arthritis.
- Sulindac tablets are taken by mouth twice a day with food.
- Sulindac tablets should not exceed the maximum daily amount set by the label and your prescriber.
- Sulindac tablets are usually needed for about 1 to 2 weeks for acute painful shoulder and about 1 week for acute gout.
Sulindac on the U.S. market: products, makers and brands
How Sulindac appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
7 companies list 14 Sulindac product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 1978. Brand names on the directory include Clinoril; the rest are generics.
Also listed with the FDA, not a patient dose form: Powder (5) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Sulindac is used (Medicaid data)
A general measure of how commonly Sulindac is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Sulindac is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Sulindac prescribed? Of the 1,601 medications we measure, Sulindac ranks #624 by Medicaid prescriptions — more than 61% of them.
Utilization by Sulindac product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
sulindac 200 MG Oral Tablet Most dispensed
Summed across the 6 of 65 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 198239
sulindac 150 MG Oral Tablet
Summed across the 5 of 30 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 198238
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Sulindac, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 11 of 95 listed Sulindac NDCs with Medicaid activity.
Compare Sulindac products
A representative set of FDA-listed product records for Sulindac — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| 200 mg | Oral | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 150 mg | Oral | Actavis Pharma, Inc. | ANDA | View NDC → |
| 200 mg | Oral | Actavis Pharma, Inc. | ANDA | View NDC → |
| 150 mg | Oral | Epic Pharma, LLC | ANDA | View NDC → |
| 200 mg | Oral | Epic Pharma, LLC | ANDA | View NDC → |
| 150 mg | Oral | PD-Rx Pharmaceuticals, Inc. | ANDA | View NDC → |
| 200 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 200 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 150 mg | Oral | PuraCap Laboratories LLC dba Blu Pharmaceuticals | ANDA | View NDC → |
| 200 mg | Oral | PuraCap Laboratories LLC dba Blu Pharmaceuticals | ANDA | View NDC → |
| 150 mg | Oral | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 200 mg | Oral | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
Showing 14 of 14 products — FDA National Drug Code Directory. See every product, package size and price: browse all 14 Sulindac NDCs →
Sulindac side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Sulindac — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Sulindac in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Sulindac FDA approval history
How Sulindac went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Sulindac recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Sulindac recalls since July 2021.
✅No Sulindac recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 10237 1 dose form · 3 strengths
-
Dose form (SCDF) Oral Tablet RxCUI 374003In current FDA listings
Look up RxCUI 10237 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Sulindac supply and shortage status
Whether Sulindac is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Sulindac costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Tablet · Oral | 200 mg | $0.221 per tablet | NDC details & price history |
| Tablet · Oral | 150 mg | $0.189 per tablet | NDC details & price history |
| Tablet | 200 mg | $0.221 per tablet | NDC details & price history |
| Tablet | 150 mg | $0.189 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Sulindac brand names
Sulindac is sold under one brand name in the FDA directory — Clinoril. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Sulindac: manufacturers and labelers
7 companies list Sulindac products with the FDA. By number of product records, the largest are PD-Rx Pharmaceuticals, Inc., A-S Medication Solutions, Actavis Pharma, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sulindac drug class (RxNorm)
Sulindac belongs to the Nonsteroidal Anti-inflammatory Drug class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Sulindac page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Sun Pharmaceutical Industries, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →